Primary Antibody Deficiency in a Tertiary Referral Hospital: A 30-Year Experiment

Mohammadinejad P
Pourhamdi S
Abolhassani H
Mirminachi B
Havaei A
Masoom SN
Sadeghi B
Ghajar A
Afarideh M
Parvaneh N
Mirsaeed-Ghazi B
Movahedi M
Gharagozlou M
Chavoushzadeh Z
Mahdaviani A
Zandieh F
Sherkat R
Sadeghi-Shabestari M
Faridhosseini R
Jabbari-Azad F
Ahanchian H
Zandkarimi M
Cherghi T
Fayezi A
Mohammadzadeh I
Amin R
Aleyasin S
Moghtaderi M
Ghaffari J
Bemanian M
Shafiei A
Kalantari N
Ahmadiafshar A
Khazaei HA
Mohammadi J
Nabavi M
Rezaei N
Aghamohammadi A


Primary antibody deficiency (PAD) is the most common group of primary immunodeficiency disorders (PID), with a broad spectrum of clinical features ranging from severe and recurrent infections to asymptomatic disease.


The current study was performed to evaluate and compare demographic and clinical data in the most common types of PAD.


We performed a retrospective review of the medical records of all PAD patients with a confirmed diagnosis of common variable immunodeficiency (CVID), hyper IgM syndrome (HIgM), selective IgA deficiency (SIgAD), and X-linked agammaglobulinemia (XLA) who were diagnosed during the last 30 years at the Children's Medical Center, Tehran, Iran.


A total number of 280 cases of PAD (125 CVID, 32 HIgM, 63 SIgAD, and 60 XLA) were enrolled in the study. The median (range) age at the onset of disease in CVID, HIgM, SIgAD, and XLA was 2 (0-46), 0.91 (0-9), 1 (0-26), and 1 (0-10) years, respectively. Gastrointestinal infections were more prevalent in CVID patients, as were central nervous system infections in XLA patients. Autoimmune complications were more prevalent in HIgM patients, malignancies in CVID patients, and allergies in SIgAD patients. The mortality rate for CVID, HIgM, and XLA was 27.2%, 28.1%, and 25%, respectively. No deaths were reported in SIgAD patients.


SIgAD patients had the best prognosis. While all PAD patients should be monitored for infectious complications, special attention should be paid to the finding of malignancy and autoimmune disorders in CVID and HIgM patients, respectively.


Contact Us

Research Center for Immunodeficiencies

Address: Pediatrics Center of Excellence, Children’s Medical Center Hospital, 62 Qarib St., Keshavarz Blvd., Tehran 14194, Iran

Research Center For immunodeficiency

Research Center For immunodeficiency